行情

CEMI

CEMI

Chembio诊断
NASDAQ

实时行情|Nasdaq Last Sale

0.9300
-0.0700
-7.00%
盘后: 0.9500 +0.02 +2.15% 18:32 01/21 EST
开盘
1.000
昨收
1.000
最高
1.030
最低
0.9001
成交量
86.57万
成交额
--
52周最高
8.75
52周最低
0.9001
市值
2,794.20万
市盈率(TTM)
-0.7357
分时
5日
1月
3月
1年
5年
Penbrook Management LLC Buys Cohu Inc, Kulicke & Soffa Industries Inc, PubMatic Inc, Sells ...
New York, NY, based Investment company Penbrook Management LLC (Current Portfolio) buys Cohu Inc, Kulicke & Soffa Industries Inc, PubMatic Inc, Chevron Corp, Intra-Cellular Therapies Inc, sells Nuance Communications Inc, Aspen Group Inc, The One Group Hosp...
GuruFocus.com · 01/10 22:38
Chembio Diagnostics appoints CFO
Chembio Diagnostics (NASDAQ:CEMI) appointed Larry Steenvoorden as CFO, effective immediately. Steenvoorden served as a senior director at Accordion Partners, providing CFO advisory services to private equity backed companies for the
Seekingalpha · 01/05 21:12
28 Stocks Moving In Wednesday's Mid-Day Session
Gainers Puxin Limited (NYSE: NEW) jumped 100.5% to $0.6016 after reporting results for the second quarter.
Benzinga · 2021/12/29 17:01
MedAvail, Altamira Therapeutics leads healthcare gainers; Chembio Diagnostics, Gamida Cell among major losers
Gainers: MedAvail (NASDAQ:MDVL) +17%, Altamira Therapeutics (NASDAQ:CYTO) +17%, Orchard Therapeutics (NASDAQ:ORTX) +10%,Biofrontera (NASDAQ:BFRI) +9%, XORTX Therapeutics (NASDAQ:XRTX) +7%. Losers: Chembio Diagnostics (NASDAQ:CEMI) -16%, Gamida Cell (NASDAQ...
Seekingalpha · 2021/12/29 16:03
FuelCell Energy, PyroGenesis Canada among premarket losers' pack
Applied UV (NASDAQ:AUVI) -22% on pricing $8.0 million public offering Chembio Diagnostics (NASDAQ:CEMI) -21% after FDA declined to review EUA application for COVID/Flu test. FuelCell Energy (NASDAQ:FCEL) -14% on Q4 earnings release. PyroGenesis Canada (NAS...
Seekingalpha · 2021/12/29 13:14
Chembio Diagnostics drops 20% after FDA declined to review EUA application for COVID/Flu test
Chembio Diagnostics (NASDAQ:CEMI) down 20% premarket after the FDA notified the company that it was declining to review its application for an emergency use authorization (EUA) for the DPP Respiratory Antigen Panel.
Seekingalpha · 2021/12/29 12:55
21 Stocks Moving in Wednesday's Pre-Market Session
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) rose 95.5% to $2.19 in pre-market trading after surging 43% on Tuesday.
Benzinga · 2021/12/29 11:40
BRIEF-Chembio Diagnostics Says FDA Declined To Review Co's Application For EUA For DPP Respiratory Antigen Panel
reuters.com · 2021/12/28 22:33
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解CEMI最新的财务预测,通过CEMI每股收益,每股净资产,每股现金流等数据分析Chembio诊断近期的经营情况,然后做出明智的投资选择。
分析师评级

2位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

0.00%强力推荐
0.00%买入
100.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测CEMI价格均价为8.00,最高价位8.00,最低价为8.00。
最高8.00
均价8.00
最低8.00
现价0.9300
EPS
实际EPS
预期EPS
-0.36-0.27-0.18-0.09
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
机构持股
总机构数: 91
机构持股: 576.40万
持股比例: 19.18%
总股本: 3,004.51万
类型机构数股数
增持
17
50.29万
建仓
8
32.11万
减持
14
78.17万
平仓
21
91.81万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
制药
-0.92%
制药与医学研究
-1.11%
高管信息
Chairman/Executive Director
Gail Page
Non-Executive Chairman/Independent Director
Katherine Davis
President/Chief Executive Officer/Director
Richard Eberly
Chief Financial Officer
Larry Steenvoorden
Executive Vice President/Chief Technology Officer/Chief Scientific Officer
Javan Esfandiari
Chief Accounting Officer/Vice President - Finance
Atif Rizvi
Independent Director
David Acheson
Independent Director
David Bespalko
Independent Director
John Potthoff
暂无数据
CEMI 简况
Chembio Diagnostics Inc是一家为检测和诊断传染性疾病提供即时诊断产品的供应商。该公司主要致力于基于其双路径平台(DPP)来扩展其产品组合。该公司的产品包括用于检测人类免疫缺陷病毒(HIV)1/2抗体的快速测试,以及用于检测HIV和梅毒抗体的多重快速测试。该公司的即时护理传染病产品组合由多种商业产品组成,只需一滴指尖血就能完成,并在大约15分钟内提供结果。该公司的产品包括DPP HIV 1/2,DPP HIV-Syphilis,DPP Syphilis Screen and Confirm,DPP Zika,DPP Leishmaniasis,STAT-PAK HIV 1/2,STAT-PAK Chagas,SURE CHECK HIV 1/2和SURE CHECK HIV 1/2 Self- Test。

微牛提供Chembio Diagnostics Inc(NASDAQ-CEMI)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的CEMI股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易CEMI股票基本功能。